Aharon Schwartz
CIK 1625184 · last filed 2025-09-04
Aharon Schwartz is a corporate insider who has filed 12 SEC Form 4 insider transactions across 2 companies since 2018. The most recent filing, for PLX, was dated Sep 4, 2025. Across all open-market trades the lifetime net is +$954.7K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $648.9K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$648.9K
2
12
$954.7K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PLX | Director | 310,500 | $2.09 | $648.9K | $517.0K | 7 | 2025-09-04 |
| Foamix Pharmaceuticals Ltd. (FOMX) Delisted | Director | 50,000 | — | — | $437.8K | 4 | 2020-03-03 |
Recent Filings
12 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-09-04 | PLX | Grant (A) | +7,500 | $0 | EDGAR |
| 2025-08-12 | PLX | Buy (P) | +129,000 | $205.9K | EDGAR |
| 2023-10-03 | PLX | Grant (A) | — | $0 | EDGAR |
| 2023-01-05 | PLX | Buy (P) | +110,000 | $155.8K | EDGAR |
| 2022-09-09 | PLX | Grant (A) | — | $0 | EDGAR |
| 2020-04-13 | PLX | Buy (P) | +64,000 | $155.3K | EDGAR |
| 2020-03-11 | — | Disp (D) | −112,200 | $0 | |
| 2020-03-03 | Foamix Pharmaceuticals Ltd. (FOMX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-01-22 | PLX | Grant (A) | — | $0 | EDGAR |
| 2019-05-20 | Foamix Pharmaceuticals Ltd. (FOMX) Delisted | Grant (A) | — | $0 | EDGAR |